Phase IIa study of RNS60 in multiple sclerosis initiated
Phase IIa study of RNS60 in multiple sclerosis initiated
Revalesio Corporation has announced a new collaboration with noted neurologist Dr. Roland Martin, Head of Neuroimmunology and MS Research at the Department of Neurology, University Hospital Zurich. Dr. Martin will be conducting a Phase IIa clinical trial of RNS60 in patients with relapsing-remitting multiple sclerosis (RRMS or MS). With 30 years experience, Dr. Martin is a recognized leader in the field of neuroimmunology and multiple sclerosis research....... Read More - http://www.ms-uk.org/emergingtherapies
MS-UK - http://www.ms-uk.org/
-
- Family Elder
- Posts: 1190
- Joined: Tue Oct 09, 2012 6:33 am
Re: Phase IIa study of RNS60 in multiple sclerosis initiated
Considering the origins of rns60, it's pretty incredible that it's landed on msuk. Can't wait to see study results.
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1941 Views
-
Last post by DIM
-
- 0 Replies
- 1775 Views
-
Last post by frodo
-
- 0 Replies
- 1570 Views
-
Last post by frodo
-
- 1 Replies
- 1828 Views
-
Last post by frodo
-
- 0 Replies
- 1628 Views
-
Last post by frodo
-
- 0 Replies
- 1873 Views
-
Last post by NHE
-
- 0 Replies
- 3623 Views
-
Last post by frodo
-
- 0 Replies
- 2213 Views
-
Last post by frodo
-
- 0 Replies
- 1256 Views
-
Last post by frodo